143 related articles for article (PubMed ID: 36388433)
1. Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients.
Huo Q; Hu J; Hou B; Zhao M; Han X; Du Y; Li Y
Pathol Oncol Res; 2022; 28():1610396. PubMed ID: 36388433
[No Abstract] [Full Text] [Related]
2. UBR5 regulates proliferation and radiosensitivity in human laryngeal carcinoma via the p38/MAPK signaling pathway.
Wang K; Tang J; Liu X; Wang Y; Chen W; Zheng R
Oncol Rep; 2020 Aug; 44(2):685-697. PubMed ID: 32468011
[TBL] [Abstract][Full Text] [Related]
3. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
4. UBR5 oncogene as an indicator of poor prognosis in gastric cancer.
Ding F; Zhu X; Song X; Yuan P; Ren L; Chai C; Zhou W; Li X
Exp Ther Med; 2020 Nov; 20(5):7. PubMed ID: 32934672
[TBL] [Abstract][Full Text] [Related]
5. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
[TBL] [Abstract][Full Text] [Related]
6. UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin.
Yang Y; Zhao J; Mao Y; Lin G; Li F; Jiang Z
Breast Cancer Res Treat; 2020 Dec; 184(3):699-710. PubMed ID: 32914356
[TBL] [Abstract][Full Text] [Related]
7. UBR5 promotes migration and invasion of glioma cells by regulating the ECRG4/NF-ҡB pathway.
Wu Q; Liu L; Feng Y; Wang L; Liu X; Li Y
J Biosci; 2022; 47():. PubMed ID: 36226349
[TBL] [Abstract][Full Text] [Related]
8. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
9. UBR5 inhibits the radiosensitivity of non-small cell lung cancer cells via the activation of the PI3K/AKT pathway.
Gu YF; Ge XP
J Investig Med; 2021 Jun; 69(5):970-975. PubMed ID: 33811132
[TBL] [Abstract][Full Text] [Related]
10. The role of UBR5 in tumor proliferation and oncotherapy.
Hu B; Chen S
Gene; 2024 May; 906():148258. PubMed ID: 38331119
[TBL] [Abstract][Full Text] [Related]
11. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract][Full Text] [Related]
12. UBR5 promotes cell proliferation and inhibits apoptosis in colon cancer by destablizing P21.
Ji SQ; Zhang YX; Yang BH
Pharmazie; 2017 Jul; 72(7):408-413. PubMed ID: 29441938
[TBL] [Abstract][Full Text] [Related]
13. Modulation of myocardin function by the ubiquitin E3 ligase UBR5.
Hu G; Wang X; Saunders DN; Henderson M; Russell AJ; Herring BP; Zhou J
J Biol Chem; 2010 Apr; 285(16):11800-9. PubMed ID: 20167605
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancer.
Liu S; Jiang H; Wen H; Ding Q; Feng C
Oncol Rep; 2018 May; 39(5):2127-2135. PubMed ID: 29512774
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of UBR5 promotes tumor growth in gallbladder cancer via PTEN/PI3K/Akt signal pathway.
Zhang Z; Zheng X; Li J; Duan J; Cui L; Yang L; Zhang L; Zhang Q; Wang X
J Cell Biochem; 2019 Jul; 120(7):11517-11524. PubMed ID: 30775814
[TBL] [Abstract][Full Text] [Related]
16.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract][Full Text] [Related]
17. Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer.
Xie Z; Liang H; Wang J; Xu X; Zhu Y; Guo A; Shen X; Cao F; Chang W
Oncotarget; 2017 Dec; 8(64):108079-108092. PubMed ID: 29296225
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
19. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
20. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
